11 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
10560740	23	The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives.	Smithkline Beecham Pharmaceuticals
15055990	37	Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.	Wyeth Research
14521407	87	Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.	Glaxosmithkline
12067545	22	Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability.	Glaxosmithkline
11754575	51	Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality.	Glaxosmithkline
10091700	36	Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism.	Smithkline Beecham Pharmaceuticals
9934494	20	Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease.	Smithkline Beecham Pharmaceuticals
9871780	85	Inhibition of human cytomegalovirus protease N(o) with monocyclic beta-lactams.	Boehringer Ingelheim (Canada)
9871686	23	Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease.	Glaxo Wellcome Research and Development
22299583	34	Tripeptides with non-code amino acids as potential serine proteases inhibitors.	Medical University of Bialystok
15908206	164	Discovery of potent and selective orally bioavailable beta-substituted phenylalanine derived dipeptidyl peptidase IV inhibitors.	Merck Research Laboratories